Remission From ‘Treatment-Resistant’ Schizophrenia Possible With Underutilized Drug: Psychiatrist

Bethany Yeiser is now free of severe schizophrenia symptoms after starting clozapine in 2008, allowing her to graduate college and start the CURESZ Foundation.
Remission From ‘Treatment-Resistant’ Schizophrenia Possible With Underutilized Drug: Psychiatrist
Bethany Yeiser reached remission from schizophrenia on the antipsychotic drug, clozapine, allowing her to finish her degree and start the CURESZ Foundation. Courtesy of Bethany Yeiser
|Updated:
0:00

Before the onset of severe, treatment-resistant schizophrenia, Bethany Yeiser was a star honors student. She won a half-tuition scholarship to study biochemistry and molecular biology at the University of Southern California in 1999 and managed to publish three papers as an undergraduate, with one appearing in the prestigious journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Amid the initial success, a storm was brewing in Ms. Yeiser’s mind, threatening to unravel every facet of her life. After her grades slowly declined her first three years of college, she took a two-and-a-half-month trip to Africa. The journey became an obsession, making the isolated undergrad forget her studies.

Jacob Burg
Jacob Burg
Author
Jacob Burg reports on national politics, aerospace, and aviation for The Epoch Times. He previously covered sports, regional politics, and breaking news for the Sarasota Herald Tribune.
Related Topics